American Biogenetic Sciences, Inc. (ABS) based in Copiague, New York, has a dual strategy of pursuing the development and commercialization of diagnostic tests for the detection of cardiovascular and infectious disease, and treatments for neurological disorders such as epilepsy, migraine, mania, Parkinson's and Alzheimer's disease. ABS also seeks out new technologies and conducts research and development throughout its Global Scientific Network, in the U.S., Europe, Israel, Russia and China. The company's enabling technology includes a patented Antigen-Free mouse colony which allows for the generation of highly specific monoclonal antibodies (Mabs), that cannot be produced by conventional systems, cialis generico Italia .